New Drug Update 2023

This program will expire and must be completed by 07/27/26.

** Please note this program was a part of the VOC 2023. You will not want to choose this program if you completed this individual program as part of the VOC 2023. **

In this presentation, the presenter will give an update on the newly approved drugs for 2023. The new therapies for the treatment of common chronic diseases and the pharmacology and clinical use of select drugs will be reviewed. 

Learning Objectives:
·    Learners will analyze, identify, and define the indications for recently approved prescription medications.
·    Learners will analyze and assess how the newly approved drugs interact with other drugs and what their place is in therapy. 
·    Learners will assess and apply new drugs and therapies to treat their patients with chronic diseases.
·    Learners will explain key counseling points and side effects for each new medication.

Accreditation Statement:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.  MAOPS designates this program for a maximum of 1 AOA Category 1-A CME Credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation.

The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)ä.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Disclosure:
None of the planners for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Grievance Policy for AOA Credit:
All grievances should be in writing and should specify the nature of the grievance.  Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee.  All grievances will receive an initial response in writing within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.